GSK
GSK buys liver disease drug
GSK acquires efimosfermin, a drug candidate for the liver disease MASH, from Boston Pharmaceuticals for USD 1,2 billion. The drug is ready for...
Targinta CEO: "Strong interest in ADCs in 2023"
In 2023, we have seen several significant deals...
Iconovo makes progress in the out-licensing process for ICOpre
Iconovo is approaching out-licensing of the ICOpre inhaler through...
Drugs against RSV give hope to COPD patients
RS virus infections can lead to serious conditions for patients...
News roundup Thursday, March 30
The latest from BioStock
GSK closes RA project
Yesterday, British pharmaceutical giant GSK announced that they...
The Ukraine crisis – an ethical dilemma for the life science sector
Russia's inhumane invasion of Ukraine is putting pressure on the life science sector....
Eurocine Vaccines CEO on the chlamydia project and portfolio building
Vaccine developer Eurocine Vaccines is currently in the process of redeeming...
Iconovo looks to the USA where it now meets quality requirements
One of Iconovo's goals is to launch future...
Increased market potential for Iconovo's inhalation platforms
Swedish inhalation company Iconovo offers a faster path to...
Iconovo intensifies global business development
Iconovo had a successful first half of the year, as shown...
Iconovo's new CEO brings business development perspective
So far, 2020 has brought several advances for Iconovo...
Notes
Cantargia publishes data for nadunolimab in lung cancer
Genmab reports sales of DARZALEX
AlzeCure receives additional subscription commitments of SEK 7 million
AstraZeneca updates on phase III study
Orexo maintains full-year forecast despite currency headwinds
NEWSLETTER
NEWS
Biovica's blood test provides new answers for cancer care
Green light for PHI to step up its commercial strategy
Enzymatica's CEO comments on his resignation
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The market is taking Trump's tariff threat in stride
The EU's new life science strategy – a step in the right direction or just fluff?
